Nvidia and Eli Lilly announced Monday a five-year, over $1 billion co-innovation AI lab to speed drug discovery, with a Bay Area site opening targeted for the end of March. The lab will prioritize large-scale lab "ground truth" data and multimodal biology foundation models, combine Nvidia compute (DGX, Vera Rubin) with Lilly expertise, and tighten experimental-feedback loops.
Key Points
- 1Announce a five-year, over $1 billion AI lab to accelerate drug discovery, opening targeted end of March
- 2Prioritize large-scale lab 'ground truth' data generation to train multimodal biology foundation models and tighten loops
- 3Enable faster experiments, candidate selection, and scale across manufacturing and commercial operations if validated
Scoring Rationale
High strategic and industry impact from a verified billion-dollar lab, but practical outcomes remain unproven until results appear.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
